Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
19 | 49662076 | missense variant | C/G;T | snv | 4.0E-05 |
|
0.800 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
0.925 | 0.080 | 19 | 49665875 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 19 | 49665875 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
19 | 49662445 | missense variant | C/T | snv | 1.0E-04 | 1.4E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
19 | 49662445 | missense variant | C/T | snv | 1.0E-04 | 1.4E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
19 | 49662445 | missense variant | C/T | snv | 1.0E-04 | 1.4E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
19 | 49662445 | missense variant | C/T | snv | 1.0E-04 | 1.4E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
19 | 49662445 | missense variant | C/T | snv | 1.0E-04 | 1.4E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
19 | 49662445 | missense variant | C/T | snv | 1.0E-04 | 1.4E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
0.925 | 0.080 | 19 | 49665614 | 5 prime UTR variant | G/A | snv | 0.37 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.160 | 19 | 49665763 | 5 prime UTR variant | T/C | snv | 0.39 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2009 | 2014 | |||||||
|
19 | 49660781 | frameshift variant | G/- | delins | 4.1E-06 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.882 | 0.160 | 19 | 49665763 | 5 prime UTR variant | T/C | snv | 0.39 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.160 | 19 | 49665763 | 5 prime UTR variant | T/C | snv | 0.39 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.040 | 19 | 49665670 | splice donor variant | A/C;T | snv | 0.36 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.040 | 19 | 49665670 | splice donor variant | A/C;T | snv | 0.36 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 19 | 49665614 | 5 prime UTR variant | G/A | snv | 0.37 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 19 | 49664469 | 5 prime UTR variant | C/G;T | snv | 0.14; 6.9E-06 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 19 | 49659652 | missense variant | C/A;G | snv | 0.39 | 0.44 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.925 | 0.080 | 19 | 49659652 | missense variant | C/A;G | snv | 0.39 | 0.44 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 |